MBX (STOCKS)
MBX Biosciences, Inc. Common Stock
$67.080000
+0.110000 (+0.16%)
Prev close: $66.970000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Steven L. Hoerter
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $3,355.47M
- Employees
- 43
- P/E (TTM)
- -27.87
- P/B (TTM)
- 7.84
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
5
Strong Buy
9
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Jun 2026 (Q2)
|
$-0.78 | $-0.64 | -0.1415 | -22.16% |
|
Mar 2026 (Q1)
|
$-0.51 | $-0.59 | +0.0784 | +13.32% |
|
Dec 2025 (Q4)
|
$-0.49 | $-0.62 | +0.1255 | +20.39% |
|
Sep 2025 (Q3)
|
$-0.63 | $-0.70 | +0.0707 | +10.09% |
Financial Statements
| Revenues | $0.00 |
| Operating Expenses | $117.92M |
| Research and Development | $88.49M |
| Other Operating Expenses | $29.43M |
| Operating Income/Loss | -$117.92M |
| Income/Loss From Continuing Operations After Tax | -$104.32M |
| Income/Loss From Continuing Operations Before Tax | -$104.32M |
| Net Income/Loss | -$104.29M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$104.32M |
| Net Income/Loss Available To Common Stockholders, Basic | -$104.29M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$2.36 |
| Diluted Earnings Per Share | -$2.36 |
| Basic Average Shares | 131,288,587 |
| Diluted Average Shares | 131,288,587 |
| Assets | $435.91M |
| Current Assets | $427.86M |
| Cash | $418.60M |
| Other Current Assets | $9.26M |
| Noncurrent Assets | $8.05M |
| Fixed Assets | $4.66M |
| Other Non-current Assets | $3.38M |
| Liabilities | $26.37M |
| Current Liabilities | $23.66M |
| Accounts Payable | $4.36M |
| Other Current Liabilities | $19.30M |
| Noncurrent Liabilities | $2.71M |
| Equity | $409.54M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $409.54M |
| Liabilities And Equity | $435.91M |
| Net Cash Flow From Operating Activities | -$82.67M |
| Net Cash Flow From Operating Activities, Continuing | -$82.67M |
| Net Cash Flow From Investing Activities | -$180.80M |
| Net Cash Flow From Investing Activities, Continuing | -$180.80M |
| Net Cash Flow From Financing Activities | $278.02M |
| Net Cash Flow From Financing Activities, Continuing | $278.02M |
| Net Cash Flow | $14.55M |
| Net Cash Flow, Continuing | $14.55M |
| Comprehensive Income/Loss | -$104.89M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$105.53M |
| Other Comprehensive Income/Loss | -$59.29M |
| Other Comprehensive Income/Loss Attributable To Parent | -$1.23M |